Nuveen Asset Management, LLC Reata Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $1.35 Million - $1.8 Million	-17,082 Reduced 15.37%	94,039 $9.59 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $123,585 - $373,239	4,006 Added 3.74%	111,121 $10.1 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $73,493 - $139,720	-3,318 Reduced 3.0%	107,115 $4.07 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $62,364 - $117,242	-3,213 Reduced 2.83%	110,433 $2.78 Million
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $168,040 - $296,161	8,114 Added 7.69%	113,646 $3.45 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $195,782 - $321,433	8,117 Added 8.33%	105,532 $3.99 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $190,051 - $823,434	-7,421 Reduced 7.08%	97,415 $2.57 Million
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $6.16 Million - $8.81 Million	-61,631 Reduced 37.02%	104,836 $10.5 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $2.97 Million - $5.74 Million	37,961 Added 29.54%	166,467 $23.6 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $188,594 - $265,752	2,001 Added 1.58%	128,506 $12.8 Million
Q4 2020 May 17, 2021	SELL	$102.03 - $184.62 $498,722 - $902,422	-4,888 Reduced 3.72%	126,505 $15.6 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $3.08 Million - $5.57 Million	30,173 Added 29.81%	131,393 $16.2 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $912,852 - $1.59 Million	-9,760 Reduced 8.79%	101,220 $9.86 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $9.84 Million - $13.8 Million	-77,895 Reduced 41.24%	110,980 $17.3 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $3.1 Million - $6.18 Million	24,949 Added 15.22%	188,875 $27.3 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $763,522 - $2.23 Million	-10,239 Reduced 5.88%	163,926 $33.5 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $2.77 Million - $3.72 Million	38,853 Added 28.71%	174,165 $14 Million
Q2 2019 Aug 15, 2019	BUY	$77.72 - $94.35 $10.1 Million - $12.3 Million	130,494 Added 2708.47%	135,312 $12.8 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $250,054 - $490,424	4,818 New	4,818 $412,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account